List of Tables
    Table 1. Insulin Glargine CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
    Table 2. Insulin Glargine Market Trends
    Table 3. Insulin Glargine Market Drivers
    Table 4. Insulin Glargine Market Challenges
    Table 5. Insulin Glargine Market Restraints
    Table 6. Global Insulin Glargine Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Insulin Glargine Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Insulin Glargine Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Insulin Glargine Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Insulin Glargine Manufacturers in Global Market, Ranking by Revenue (2021)
    Table 11. Global Insulin Glargine Revenue by Manufacturer, (US$ Million), 2017-2022
    Table 12. Global Insulin Glargine Revenue Share by Manufacturer, 2017-2022
    Table 13. Global Insulin Glargine Sales by Manufacturer, (M mL), 2017-2022
    Table 14. Global Insulin Glargine Sales Share by Manufacturer, 2017-2022
    Table 15. Global Insulin Glargine Price by Manufacturer (2017-2022) & (USD/mL)
    Table 16. Global Insulin Glargine Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global Insulin Glargine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Insulin Glargine as of 2021)
    Table 18. Top Players of Insulin Glargine in Global Market, Headquarters and Distribution of Producing Region
    Table 19. Manufacturers Insulin Glargine Product Type
    Table 20. Date of International Manufacturers Enter into Insulin Glargine Market
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Top Insulin Glargine Players in United States Market, Ranking by Revenue (2021)
    Table 23. United States Insulin Glargine Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 24. United States Insulin Glargine Revenue Share by Players, 2020, 2021 & 2022
    Table 25. United States Insulin Glargine Sales by Players, (M mL), 2020, 2021 & 2022
    Table 26. United States Insulin Glargine Sales Share by Players, 2020, 2021 & 2022
    Table 27. Global Insulin Glargine Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 28. Global Insulin Glargine Sales in Volume by Region (2017-2022) & (M mL)
    Table 29. Global Insulin Glargine Sales in Volume Forecast by Region (2023-2028) & (M mL)
    Table 30. Global Insulin Glargine Sales in Value by Region (2017-2022) & (US$ Million)
    Table 31. Global Insulin Glargine Sales in Value Forecast by Region (2023-2028) & (US$ Million)
    Table 32. North America Insulin Glargine Sales in Volume by Country (2017-2028) & (M mL)
    Table 33. North America Insulin Glargine Sales in Value by Country (2017-2028) & (US$ Million)
    Table 34. Asia Pacific Insulin Glargine Sales in Volume by Region (2017-2028) & (M mL)
    Table 35. Asia Pacific Insulin Glargine Sales in Value by Region (2017-2028) & (US$ Million)
    Table 36. Europe Insulin Glargine Sales in Volume by Country (2017-2028) & (M mL)
    Table 37. Europe Insulin Glargine Sales in Value by Country (2017-2028) & (US$ Million)
    Table 38. Latin America Insulin Glargine Sales in Volume by Country (2017-2028) & (M mL)
    Table 39. Latin Americaa Insulin Glargine Sales in Value by Country (2017-2028) & (US$ Million)
    Table 40. Middle East and Africa Insulin Glargine Sales in Volume by Country (2017-2028) & (M mL)
    Table 41. Middle East and Africa Insulin Glargine Sales in Value by Country (2017-2028) & (US$ Million)
    Table 42. Sanofi Corporation Information
    Table 43. Sanofi Description and Business Overview
    Table 44. Sanofi Insulin Glargine Sales (M mL), Revenue (US$ Million), Price (USD/mL) and Gross Margin (2017-2022)
    Table 45. Sanofi Insulin Glargine Product
    Table 46. Sanofi Recent Development
    Table 47. Eli Lilly Corporation Information
    Table 48. Eli Lilly Description and Business Overview
    Table 49. Eli Lilly Insulin Glargine Sales (M mL), Revenue (US$ Million), Price (USD/mL) and Gross Margin (2017-2022)
    Table 50. Eli Lilly Product
    Table 51. Eli Lilly Recent Development
    Table 52. Viatris Corporation Information
    Table 53. Viatris Description and Business Overview
    Table 54. Viatris Insulin Glargine Sales (M mL), Revenue (US$ Million), Price (USD/mL) and Gross Margin (2017-2022)
    Table 55. Viatris Product
    Table 56. Viatris Recent Development
    Table 57. Gan&Lee Pharmaceuticals Corporation Information
    Table 58. Gan&Lee Pharmaceuticals Description and Business Overview
    Table 59. Gan&Lee Pharmaceuticals Insulin Glargine Sales (M mL), Revenue (US$ Million), Price (USD/mL) and Gross Margin (2017-2022)
    Table 60. Gan&Lee Pharmaceuticals Product
    Table 61. Gan&Lee Pharmaceuticals Recent Development
    Table 62. Tonghua Dongbao Pharmaceutical Corporation Information
    Table 63. Tonghua Dongbao Pharmaceutical Description and Business Overview
    Table 64. Tonghua Dongbao Pharmaceutical Insulin Glargine Sales (M mL), Revenue (US$ Million), Price (USD/mL) and Gross Margin (2017-2022)
    Table 65. Tonghua Dongbao Pharmaceutical Product
    Table 66. Tonghua Dongbao Pharmaceutical Recent Development
    Table 67. United Laboratories International Corporation Information
    Table 68. United Laboratories International Description and Business Overview
    Table 69. United Laboratories International Insulin Glargine Sales (M mL), Revenue (US$ Million), Price (USD/mL) and Gross Margin (2017-2022)
    Table 70. United Laboratories International Product
    Table 71. United Laboratories International Recent Development
    Table 72. Key Raw Materials Lists
    Table 73. Raw Materials Key Suppliers Lists
    Table 74. Insulin Glargine Customers List
    Table 75. Insulin Glargine Distributors List
    Table 76. Research Programs/Design for This Report
    Table 77. Key Data Information from Secondary Sources
    Table 78. Key Data Information from Primary Sources
List of Figures
    Figure 1. Insulin Glargine Product Picture
    Figure 2. Global Insulin Glargine Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Insulin Glargine Market Size 2017-2028 (US$ Million)
    Figure 4. Global Insulin Glargine Sales 2017-2028 (M mL)
    Figure 5. United States Insulin Glargine Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 6. United States Insulin Glargine Market Size 2017-2028 (US$ Million)
    Figure 7. United States Insulin Glargine Sales 2017-2028 (M mL)
    Figure 8. United States Insulin Glargine Market Share in Global, in Value (US$ Million) 2017-2028
    Figure 9. United States Insulin Glargine Market Share in Global, in Volume (M mL) 2017-2028
    Figure 10. Insulin Glargine Report Years Considered
    Figure 11. Product Picture of Prefilled Injection
    Figure 12. Product Picture of Non-Prefilled Injection
    Figure 13. Global Insulin Glargine Market Share by Type in 2022 & 2028
    Figure 14. Global Insulin Glargine Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 15. Global Insulin Glargine Sales Market Share in Value by Type (2017-2028)
    Figure 16. Global Insulin Glargine Sales by Type (2017-2028) & (M mL)
    Figure 17. Global Insulin Glargine Sales Market Share in Volume by Type (2017-2028)
    Figure 18. Global Insulin Glargine Price by Type (2017-2028) & (USD/mL)
    Figure 19. United States Insulin Glargine Market Share by Type in 2022 & 2028
    Figure 20. United States Insulin Glargine Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 21. United States Insulin Glargine Sales Market Share in Value by Type (2017-2028)
    Figure 22. United States Insulin Glargine Sales by Type (2017-2028) & (M mL)
    Figure 23. United States Insulin Glargine Sales Market Share in Volume by Type (2017-2028)
    Figure 24. United States Insulin Glargine Price by Type (2017-2028) & (USD/mL)
    Figure 25. Product Picture of Type 1 Diabetes Treatment
    Figure 26. Product Picture of Type 2 Diabetes Treatment
    Figure 27. Global Insulin Glargine Market Share by Application in 2022 & 2028
    Figure 28. Global Insulin Glargine Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 29. Global Insulin Glargine Sales Market Share in Value by Application (2017-2028)
    Figure 30. Global Insulin Glargine Sales by Application (2017-2028) & (M mL)
    Figure 31. Global Insulin Glargine Sales Market Share in Volume by Application (2017-2028)
    Figure 32. Global Insulin Glargine Price by Application (2017-2028) & (USD/mL)
    Figure 33. United States Insulin Glargine Market Share by Application in 2022 & 2028
    Figure 34. United States Insulin Glargine Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 35. United States Insulin Glargine Sales Market Share in Value by Application (2017-2028)
    Figure 36. United States Insulin Glargine Sales by Application (2017-2028) & (M mL)
    Figure 37. United States Insulin Glargine Sales Market Share in Volume by Application (2017-2028)
    Figure 38. United States Insulin Glargine Price by Application (2017-2028) & (USD/mL)
    Figure 39. North America Insulin Glargine Sales in Volume Growth Rate 2017-2028 (M mL)
    Figure 40. North America Insulin Glargine Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 41. U.S. Insulin Glargine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 42. Canada Insulin Glargine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 43. Europe Insulin Glargine Sales in Volume Growth Rate 2017-2028 (M mL)
    Figure 44. Europe Insulin Glargine Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 45. Germany Insulin Glargine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 46. France Insulin Glargine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 47. U.K. Insulin Glargine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 48. Italy Insulin Glargine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 49. Russia Insulin Glargine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Asia-Pacific Insulin Glargine Sales in Volume Growth Rate 2017-2028 (M mL)
    Figure 51. Asia-Pacific Insulin Glargine Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 52. China Insulin Glargine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 53. Japan Insulin Glargine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 54. South Korea Insulin Glargine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 55. India Insulin Glargine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 56. Australia Insulin Glargine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 57. China Taiwan Insulin Glargine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 58. Indonesia Insulin Glargine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 59. Thailand Insulin Glargine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 60. Malaysia Insulin Glargine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 61. Latin America Insulin Glargine Sales in Volume Growth Rate 2017-2028 (M mL)
    Figure 62. Latin America Insulin Glargine Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 63. Mexico Insulin Glargine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 64. Brazil Insulin Glargine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 65. Argentina Insulin Glargine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 66. Middle East & Africa Insulin Glargine Sales in Volume Growth Rate 2017-2028 (M mL)
    Figure 67. Middle East & Africa Insulin Glargine Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 68. Turkey Insulin Glargine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 69. Saudi Arabia Insulin Glargine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 70. UAE Insulin Glargine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 71. Insulin Glargine Value Chain
    Figure 72. Insulin Glargine Production Process
    Figure 73. Channels of Distribution
    Figure 74. Distributors Profiles
    Figure 75. Bottom-up and Top-down Approaches for This Report
    Figure 76. Data Triangulation
    Figure 77. Key Executives Interviewed